1. Introduction and motivation {#sec1}
==============================

The legacy of Benjamin Gompertz has withstood the test of time and [@b21] has been cited with increasing frequency in the last few decades[1](#fn1){ref-type="fn"} . To his credit, Benjamin Gompertz appears regularly in the pages of *Insurance: Mathematics and Economics*. Despite its age and noted empirical limitations, his eponymous law of mortality -- soon to celebrate its 200th anniversary -- is still widely used in the fields of demographics, biology, actuarial science and even financial engineering. In particular, the ability to represent important actuarial expressions in closed form via the Gamma function has made the Gompertz representation especially convenient and popular in the annuity literature. The defining characteristic of the Gompertz law of mortality, when expressed in continuous time, is the linear relationship between the log of natural mortality rates and (chronological) age $x$. The natural law is written or expressed via the following parameterization: $$\mathtt{Natural}\;\;\mathtt{Mortality}\;\;\mathtt{Rate} = \mu_{x} - \lambda = he^{gx} = \left( 1\slash b \right)e^{{(x - m)} \slash b}.$$In this expression, $\lambda \geq 0$, which is subtracted from the total hazard rate $\mu_{x} \gg \lambda$, is a non-age-dependent accidental death (a.k.a. Makeham constant) rate, and $\left( h > 0,g > 0 \right)$ or alternatively $\left( m > 0,b > 0 \right)$ determines the slope and intercept of $\ln\left\lbrack \mu_{x} - \lambda \right\rbrack$. Using the more common $\left( m,b \right)$ formulation, the parameter $m$ represents the modal value of the remaining lifetime random variable $T_{x}$, and $b$ represents a dispersion coefficient. Either way, the implicit linearity assumption is empirically valid over adult ages across most countries around the world. Gompertz--Makeham (GM) does not fit very well at young $\left( x < 30 \right)$ ages, might temporarily break-down during pandemics (such as Covid-19), and the upper bound $\left( x > 95 \right)$ is subject to some debate in the bio-demographic literature.[2](#fn2){ref-type="fn"}

At the risk of jumping too far ahead, [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"} displays the best-fitting Gompertz (and Makeham) parameters for the 38 countries listed and available in the Human Mortality Database (HMD) at the time this analysis was conducted. Both sets of $\left( h,g \right)$ and $\left( m,b \right)$ are displayed, and are in line with values used by researchers in the actuarial literature.

It is quite evident (from [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}) that although Gompertz fits the 38 countries, the best-fitting parameters are country dependent. Some experience higher mortality (and reduced longevity), while other countries experience lower mortality (and increased longevity). Mortality, and its converse longevity, are quite obviously heterogeneous. For example, $q_{65}$ in Sweden is much lower than $q_{65}$ in Russia. Interestingly, when country rates are averaged: ${\widehat{q}}_{x} = \frac{1}{38}\sum_{i = 1}^{38}q_{x}\left\lbrack i \right\rbrack$, where $i$ is the country, the aggregate curve is also well-approximated by Gompertz; even though an average Gompertz random variable is not Gompertz.Table 1aGompertz--Makeham parameters around the world: MALE.Country$\ln h\left\lbrack i \right\rbrack$$\lambda_{0}\left\lbrack i \right\rbrack$*Makeham:*$\lambda$$g\left\lbrack i \right\rbrack$$\lambda_{55}\left\lbrack i \right\rbrack$$m$$b$1. Australia−11.693$63.9 \times 10^{- 5}$$63.0 \times 10^{- 5}$$10.92\text{\%}$$0.442\text{\%}$86.789.162. Austria−10.681$3.5 \times 10^{- 5}$$1.0 \times 10^{- 5}$$9.91\text{\%}$$0.590\text{\%}$84.4910.103. Belarus−7.640$52.5 \times 10^{- 5}$$1.0 \times 10^{- 5}$$6.90\text{\%}$$2.289\text{\%}$72.0014.504. Belgium−10.656$19.6 \times 10^{- 5}$$17.0 \times 10^{- 5}$$9.89\text{\%}$$0.616\text{\%}$84.3610.115. Bulgaria−9.367$10.3 \times 10^{- 5}$$1.0 \times 10^{- 5}$$8.86\text{\%}$$1.220\text{\%}$78.3911.296. Canada−11.140$33.6 \times 10^{- 5}$$32.0 \times 10^{- 5}$$10.28\text{\%}$$0.492\text{\%}$86.239.737. Croatia−10.070$5.7 \times 10^{- 5}$$1.0 \times 10^{- 5}$$9.57\text{\%}$$0.902\text{\%}$80.6910.458. Czechia−10.150$5.3 \times 10^{- 5}$$1.0 \times 10^{- 5}$$9.60\text{\%}$$0.844\text{\%}$81.3410.429. Denmark−10.633$7.7 \times 10^{- 5}$$5.0 \times 10^{- 5}$$9.92\text{\%}$$0.630\text{\%}$83.8710.0810. Estonia−9.014$14.2 \times 10^{- 5}$$1.0 \times 10^{- 5}$$8.25\text{\%}$$1.240\text{\%}$78.9812.1111. Finland−10.391$27.4 \times 10^{- 5}$$24.0 \times 10^{- 5}$$9.59\text{\%}$$0.683\text{\%}$83.9310.4312. France−10.211$28.0 \times 10^{- 5}$$24.0 \times 10^{- 5}$$9.17\text{\%}$$0.650\text{\%}$85.2710.9013. Germany−10.631$3.7 \times 10^{- 5}$$1.0 \times 10^{- 5}$$9.90\text{\%}$$0.619\text{\%}$84.0210.1014. Greece−10.309$9.7 \times 10^{- 5}$$6.0 \times 10^{- 5}$$9.39\text{\%}$$0.645\text{\%}$84.6310.6515. Hungary−9.293$11.1 \times 10^{- 5}$$1.0 \times 10^{- 5}$$8.72\text{\%}$$1.220\text{\%}$78.5611.4616. Ireland−11.191$36.5 \times 10^{- 5}$$35.0 \times 10^{- 5}$$10.50\text{\%}$$0.527\text{\%}$85.159.5317. Israel−10.950$2.9 \times 10^{- 5}$$1.0 \times 10^{- 5}$$10.02\text{\%}$$0.482\text{\%}$86.319.9818. Italy−11.453$18.2 \times 10^{- 5}$$17.0 \times 10^{- 5}$$10.75\text{\%}$$0.454\text{\%}$85.799.3019. Japan−11.113$34.7 \times 10^{- 5}$$33.0 \times 10^{- 5}$$10.28\text{\%}$$0.505\text{\%}$85.989.7320. Korea−10.639$31.6 \times 10^{- 5}$$29.0 \times 10^{- 5}$$9.92\text{\%}$$0.648\text{\%}$83.9610.0821. Latvia−8.398$25.3 \times 10^{- 5}$$1.0 \times 10^{- 5}$$7.62\text{\%}$$1.608\text{\%}$76.4313.1222. Lithuania−8.046$35.4 \times 10^{- 5}$$1.0 \times 10^{- 5}$$7.14\text{\%}$$1.744\text{\%}$75.7514.0123. Luxembourg−11.236$2.5 \times 10^{- 5}$$1.0 \times 10^{- 5}$$10.64\text{\%}$$0.512\text{\%}$84.539.4024. Netherlands−11.432$13.2 \times 10^{- 5}$$12.0 \times 10^{- 5}$$10.80\text{\%}$$0.471\text{\%}$85.259.2625. New Zealand−11.353$44.3 \times 10^{- 5}$$43.0 \times 10^{- 5}$$10.58\text{\%}$$0.481\text{\%}$86.109.4526. Norway−11.390$29.3 \times 10^{- 5}$$28.0 \times 10^{- 5}$$10.72\text{\%}$$0.485\text{\%}$85.439.3327. Poland−9.092$13.2 \times 10^{- 5}$$1.0 \times 10^{- 5}$$8.27\text{\%}$$1.156\text{\%}$79.8012.0928. Portugal−10.208$35.0 \times 10^{- 5}$$31.0 \times 10^{- 5}$$9.35\text{\%}$$0.722\text{\%}$83.8710.7029. Russia−7.941$250.2 \times 10^{- 5}$$212.0 \times 10^{- 5}$$7.15\text{\%}$$2.161\text{\%}$74.1813.9930. Slovakia−9.511$9.1 \times 10^{- 5}$$1.0 \times 10^{- 5}$$8.93\text{\%}$$1.102\text{\%}$79.4411.2031. Slovenia−10.402$4.3 \times 10^{- 5}$$1.0 \times 10^{- 5}$$9.72\text{\%}$$0.703\text{\%}$83.0310.2932. Spain−10.737$3.4 \times 10^{- 5}$$1.0 \times 10^{- 5}$$9.87\text{\%}$$0.546\text{\%}$85.3510.1433. Sweden−11.693$20.9 \times 10^{- 5}$$20.0 \times 10^{- 5}$$11.07\text{\%}$$0.431\text{\%}$85.769.0434. Switzerland−11.551$22.1 \times 10^{- 5}$$21.0 \times 10^{- 5}$$10.79\text{\%}$$0.426\text{\%}$86.429.2735. Taiwan−9.735$92.5 \times 10^{- 5}$$86.0 \times 10^{- 5}$$8.69\text{\%}$$0.856\text{\%}$83.8811.5036. U.K.−11.230$60.5 \times 10^{- 5}$$59.0 \times 10^{- 5}$$10.47\text{\%}$$0.526\text{\%}$85.699.5537. U.S.A.−10.101$57.5 \times 10^{- 5}$$53.0 \times 10^{- 5}$$9.14\text{\%}$$0.738\text{\%}$84.3610.9438. Ukraine−8.307$169.6 \times 10^{- 5}$$143.0 \times 10^{- 5}$$7.64\text{\%}$$1.920\text{\%}$75.0913.09**Average:−10.25234.4 × 10^−5^26.6 × 10^−5^9.50%0.850%82.6610.70***HMD, Period Tables 2011 (Last accessed 15/Jan/2020).*Table 1bGompertz--Makeham parameters around the world: FEMALE.Country$\ln h\left\lbrack i \right\rbrack$$\lambda_{0}\left\lbrack i \right\rbrack$*Makeham:*$\lambda$$g\left\lbrack i \right\rbrack$$\lambda_{55}\left\lbrack i \right\rbrack$$m$$b$1. Australia−12.243$30.5 \times 10^{- 5}$$30.0 \times 10^{- 5}$$11.11\text{\%}$$0.273\text{\%}$90.409.002. Austria−11.818$2.8 \times 10^{- 5}$$2.0 \times 10^{- 5}$$10.77\text{\%}$$0.309\text{\%}$89.059.293. Belarus−10.646$70.6 \times 10^{- 5}$$68.0 \times 10^{- 5}$$9.95\text{\%}$$0.695\text{\%}$83.7810.054. Belgium−11.473$12.2 \times 10^{- 5}$$11.0 \times 10^{- 5}$$10.36\text{\%}$$0.356\text{\%}$88.839.655. Bulgaria−11.363$49.3 \times 10^{- 5}$$48.0 \times 10^{- 5}$$10.84\text{\%}$$0.552\text{\%}$84.319.226. Canada−11.656$17.0 \times 10^{- 5}$$16.0 \times 10^{- 5}$$10.45\text{\%}$$0.318\text{\%}$89.919.577. Croatia−11.693$1.9 \times 10^{- 5}$$1.0 \times 10^{- 5}$$11.07\text{\%}$$0.412\text{\%}$85.759.038. Czechia−11.846$16.8 \times 10^{- 5}$$16.0 \times 10^{- 5}$$11.17\text{\%}$$0.389\text{\%}$86.428.959. Denmark−11.530$2.1 \times 10^{- 5}$$1.0 \times 10^{- 5}$$10.60\text{\%}$$0.374\text{\%}$87.579.4310. Estonia−10.986$14.9 \times 10^{- 5}$$13.0 \times 10^{- 5}$$9.96\text{\%}$$0.460\text{\%}$87.1610.0411. Finland−11.740$7.9 \times 10^{- 5}$$7.0 \times 10^{- 5}$$10.64\text{\%}$$0.316\text{\%}$89.279.4012. France−11.509$20.1 \times 10^{- 5}$$19.0 \times 10^{- 5}$$10.08\text{\%}$$0.303\text{\%}$91.419.9213. Germany−11.773$9.9 \times 10^{- 5}$$9.0 \times 10^{- 5}$$10.79\text{\%}$$0.333\text{\%}$88.499.2714. Greece−12.483$23.4 \times 10^{- 5}$$23.0 \times 10^{- 5}$$11.59\text{\%}$$0.272\text{\%}$89.148.6315. Hungary−10.718$3.4 \times 10^{- 5}$$1.0 \times 10^{- 5}$$9.95\text{\%}$$0.585\text{\%}$84.4910.0516. Ireland−11.619$7.0 \times 10^{- 5}$$6.0 \times 10^{- 5}$$10.58\text{\%}$$0.342\text{\%}$88.619.4517. Israel−12.339$21.5 \times 10^{- 5}$$21.0 \times 10^{- 5}$$11.39\text{\%}$$0.279\text{\%}$89.258.7818. Italy−12.374$14.5 \times 10^{- 5}$$14.0 \times 10^{- 5}$$11.31\text{\%}$$0.252\text{\%}$90.148.8419. Japan−12.252$37.5 \times 10^{- 5}$$37.0 \times 10^{- 5}$$10.85\text{\%}$$0.245\text{\%}$92.449.2220. Korea−13.150$46.2 \times 10^{- 5}$$46.0 \times 10^{- 5}$$12.27\text{\%}$$0.233\text{\%}$90.108.1521. Latvia−10.467$15.1 \times 10^{- 5}$$12.0 \times 10^{- 5}$$9.56\text{\%}$$0.612\text{\%}$84.9610.4622. Lithuania−10.550$40.9 \times 10^{- 5}$$38.0 \times 10^{- 5}$$9.57\text{\%}$$0.596\text{\%}$85.7010.4523. Luxembourg−11.787$1.8 \times 10^{- 5}$$1.0 \times 10^{- 5}$$10.75\text{\%}$$0.314\text{\%}$88.909.3024. Netherlands−11.554$10.1 \times 10^{- 5}$$9.0 \times 10^{- 5}$$10.50\text{\%}$$0.352\text{\%}$88.609.5325. New Zealand−11.948$31.7 \times 10^{- 5}$$31.0 \times 10^{- 5}$$10.96\text{\%}$$0.330\text{\%}$88.869.1326. Norway−11.878$3.8 \times 10^{- 5}$$3.0 \times 10^{- 5}$$10.84\text{\%}$$0.304\text{\%}$89.069.2227. Poland−11.145$7.6 \times 10^{- 5}$$6.0 \times 10^{- 5}$$10.23\text{\%}$$0.449\text{\%}$86.699.7828. Portugal−12.120$25.6 \times 10^{- 5}$$25.0 \times 10^{- 5}$$11.10\text{\%}$$0.298\text{\%}$89.369.0129. Russia−10.971$154.9 \times 10^{- 5}$$153.0 \times 10^{- 5}$$10.34\text{\%}$$0.716\text{\%}$84.159.6730. Slovakia−11.393$6.3 \times 10^{- 5}$$5.0 \times 10^{- 5}$$10.72\text{\%}$$0.461\text{\%}$85.459.3331. Slovenia−11.635$2.0 \times 10^{- 5}$$1.0 \times 10^{- 5}$$10.64\text{\%}$$0.343\text{\%}$88.329.4032. Spain−12.223$15.5 \times 10^{- 5}$$15.0 \times 10^{- 5}$$11.02\text{\%}$$0.250\text{\%}$90.949.0833. Sweden−12.242$9.5 \times 10^{- 5}$$9.0 \times 10^{- 5}$$11.28\text{\%}$$0.276\text{\%}$89.178.8634. Switzerland−12.164$6.6 \times 10^{- 5}$$6.0 \times 10^{- 5}$$11.02\text{\%}$$0.255\text{\%}$90.399.0835. Taiwan−11.928$38.7 \times 10^{- 5}$$38.0 \times 10^{- 5}$$10.95\text{\%}$$0.342\text{\%}$88.759.1336. U.K.−11.715$26.9 \times 10^{- 5}$$26.0 \times 10^{- 5}$$10.67\text{\%}$$0.347\text{\%}$88.859.3837. U.S.A.−10.940$39.0 \times 10^{- 5}$$37.0 \times 10^{- 5}$$9.77\text{\%}$$0.458\text{\%}$88.1910.2438. Ukraine−11.257$123.4 \times 10^{- 5}$$122.0 \times 10^{- 5}$$10.79\text{\%}$$0.664\text{\%}$83.739.27**Average:−11.66125.5 × 10^−5^24.4 × 10^−5^10.70%0.386%88.079.37***HMD, Period Tables 2011 (Last accessed 15/Jan/2020)*.

What is less known to non-specialists in this field is that upon closer examination of the country-by-country parameter estimates, there is a negative relationship between the estimated (log) initial natural mortality rate $\ln\left\lbrack h \right\rbrack$, and the estimated mortality growth rate $g$. Countries with a relatively low initial natural mortality rate tend to have a higher mortality growth rate and vice versa. The exact nature of this relationship -- known as the compensation law of mortality -- will be made precise later in the paper, but can be visualized conceptually in [Fig. 1](#fig1){ref-type="fig"}. Countries with relatively low mortality rates are represented by the top lines, and countries with relatively higher mortality are represented by the bottom lines, all in log scale. In examining [Fig. 1](#fig1){ref-type="fig"} think of the (thick) middle line as representing the above mentioned global average (log) mortality rate. The relative difference in natural mortality rates declines over chronological age, so that at some advanced age the difference in mortality between countries is minimal. The essence of this paper is to *exploit* that convergence -- together with the Gompertz law -- to offer a new definition of age.

Fig. 1Visualizing Gompertz and the compensation law of mortality. Note: The *compensation law of mortality* in its strong form implies that (log) mortality rates increase linearly and then converge to a constant mortality plateau. This leads to a linear and negative relationship between the (initial natural mortality) intercept: $\ln h\left\lbrack i \right\rbrack$, and the (mortality growth rate) slope: $g\left\lbrack i \right\rbrack$, in a Gompertz regression of log mortality rate on (chronological) age. The thick line in the center is based on the global average $G$, and used to map or convert (chronological) age into a longevity-risk-adjusted global age.

1.1. A new age {#sec1.1}
--------------

Researchers in a variety of medical fields are working on uncovering bio-markers of aging which measure an individual's *true* physiological age, also known as their *biological age*. This sort of information is used to predict health needs, as well as to generate more accurate forward-looking mortality rate projections and distributions of future lifetimes. Age adjustments, which are similar to actuarial setbacks, are a refined form of the underwriting process that has been used by life insurance companies for centuries. What has received less attention in the insurance literature, however, is how to map estimated mortality rates into a consistent **longevity**-risk-adjusted global age. To fill this gap in the literature, this paper develops a consistent framework for inverting the GM law of mortality for heterogeneous populations in a manner consistent with a compensation law. While the two-stage process will be carefully explained, the end result is a simple equation which maps an individual's chronological age $x$, into a longevity-risk-adjusted global age (or L-RaG): $\xi$, which may be higher or lower than $x$, depending on the relative shape of the country-specific $q_{x}\left\lbrack i \right\rbrack$ curve relative to the global curve ${\widehat{q}}_{x}$.

So, why bother doing this? On a behavioral level, this information might offer an alternative and intuitive way of explaining longevity metrics to a wider public who struggle with probabilistic concepts.[3](#fn3){ref-type="fn"} Indeed, informing a healthy 70-year-old that they face a 20% chance of living to age 90 -- and should therefore plan for this *longevity risk* -- might not be as impactful or salient as informing them they are "really 55", on a risk-adjusted basis, or that their true age is "safer than 55". Now, this paper makes no claim about the efficacy of presenting longevity risk information in (what this author believes is) a more salient manner, and leaves that task to other (future) researchers. Rather, this paper is concerned with methodology, namely: given a large set of country mortality rates, how does one compute a *longevity-risk-adjusted global age?* And, although to modern practicing actuaries the underlying Gompertz model might appear as an archaic remnant of an era prior to spreadsheets, the Gompertz--Makeham (GM) law allows for analytic tractability that greatly benefits the inversion process at the heart of this paper.[4](#fn4){ref-type="fn"} (So yes, it is also a matter of convenience.)

The remainder of this paper is organized as follows: The next Section [2](#sec2){ref-type="sec"} provides a brief overview of what is commonly meant by *biological* age in the medical field, and how it differs from the *longevity-risk-adjusted global age*. Section [3](#sec3){ref-type="sec"} provides an overview of the statistical and methodological framework proposed in this paper. Section [4](#sec4){ref-type="sec"} gets into the details and the role of the *compensation law of mortality*, introduced by [@b19]. Readers interested in the numerical values of longevity-risk-adjusted global ages around the world can skip ahead to Section [5](#sec5){ref-type="sec"} and the associated tables. Finally, Section [6](#sec6){ref-type="sec"} concludes the paper and offers some suggestions for additional applications within the context of heterogeneous mortality and pension policy.

2. Biological versus risk-adjusted global age {#sec2}
=============================================

Generally speaking, there are two very different approaches for how to compute or measure an adjusted (non-chronological) age. The difference between the two methodologies or viewpoints is not just a matter of computational technique, but is in fact motivated by one's background, discipline and field, as well as the intended usage of the result. Although researchers themselves do not use these terms, this paper labels the two approaches a "living" (i.e., biological) methodology and a "dying" (i.e., mortality-rate) methodology. Stated quite simply, in the former (living), the benchmark for measuring true age is other people who are alive, and for the latter (dying) approach the benchmark is people who are dead.

2.1. Measuring age: The living approach {#sec2.1}
---------------------------------------

In the medical arena, to determine biological age, a researcher gathers data from a very large group of people at a wide range of ages and collects samples of their saliva, blood, and urine, to extract various physiological and molecular (DNA, RNA, etc.) variables. These measurements, which could number in the hundreds, might range from red blood cell count, hemoglobin concentration, and total cholesterol, to items such as fasting blood sugar levels, urine specific gravity, triglycerides, or the average telomere length (or ATL), which is a leading biomarker for aging, associated with the work of [@b5].

These physiological and molecular variables might then be augmented by physical variables (i.e., more easily measured, not requiring a laboratory) such as hand grip strength, visual perception, or even the number of missing teeth. Some researchers go so far as to augment their dataset with social variables, such as number of friends on Facebook, or a binary variable measuring whether they like to garden. The theory here is that anything remotely associated with the characteristics of older people can be added as a data point for measuring true age: see [@b44], [@b15], or more recently [@b28].) Each one of the elements is coded as a numerical score and every person in the sample is now associated with a vector, including, obviously, their gender. The most important number, however, which one can visually imagine as being stored at the very beginning of this long vector, is the individual's chronological age. Here we denote the i'th person's chronological age by the symbol $y\left( i \right)$, and the vector of physiological, molecular, physical and social characteristics by $x\left( j,i \right)$, where the index letter $j$ ranges from 1 to the total number of variables.

The researcher would then generate a multivariate (usually linear) regression of $y\left( i \right)$, as the dependent variable, on $x\left( j,i \right)$ (the independent variables) to obtain the best-fitting function in the sense of least squares, etc. Variables that are not statistically significant are discarded (e.g., Facebook friends) and the multivariate regression is estimated again (and again) until the process converges on a small set of variables that relate (i.e., predict) the dependent variable, which is chronological age. The best-fitting regression equation becomes the formula for *biological age*, while the individual errors in the regression are the gaps between a person's chronological age and their biological age.

The statistically-significant coefficients in this regression are declared as relevant biomarkers of aging --- and the sign of the coefficients (a.k.a. factors), determines whether scoring higher in those elements effectively makes one younger or older. This is **not** the approach taken in the current paper, but is what many (if not most) medical researchers mean by the term *biological age.* (See the recent paper by [@b4] for a comparison of *eleven* different techniques used to measure biological age.)

2.2. Biological age versus longevity risk {#sec2.2}
-----------------------------------------

Here lies the concern with (what was labeled) the *living* approach, which is a non-mortality-based approach, in determining true age. The implied age is based on how similar one is to other people, as opposed to directly estimating how long they are going to live or how soon they are likely to die --- which would be of interest to the insurance economist concerned with describing human longevity. Indeed, it is implicitly assumed that older people are more likely to die sooner, and so the older the regression-measured biological age, the lower the life expectancy. But for the most part mortality is not involved directly. Instead, the basic dataset is a cross-section of live people at different ages.

Yes, in some clinical studies, e.g. [@b28], researchers track large groups of people over time to examine if the older ones are more likely to die or if they did not live as long as their identically-aged neighbors, but this approach is generally an afterthought to the established methods, as well as requiring very long periods of time (decades, really) to establish. So, while the "living" approach does not ignore death, its focus is mainly on keeping people alive and in "young" health.

In sum, in terms of the way it is currently used and defined, the biological age literature is (i.) focused on locating people who are most similar, and (ii.) is primarily concerned with predicting functional impairments or the risk of chronic diseases. These researchers are interested in maximizing health span, not necessarily lifespan, which is why death and mortality rates are not the focus of their attention. In addition, there are several other concerns with this approach, mostly related to the statistical significance of regressions with multiple independent variables, as well as concerns about linearity assumptions.[5](#fn5){ref-type="fn"}

2.3. Measuring age based on time to death {#sec2.3}
-----------------------------------------

In contrast to the "living" methodology, the *longevity-risk-adjusted global age* -- as the name suggests -- is based on people who have died and is ultimately concerned with something much less complex than the multifaceted aspects of aging. The purpose of *longevity-risk-adjusted global age* is to better represent and explain time until death relative to the global average. This process begins by collecting data on mortality rates (only) as a function of chronological age, as well as any other characteristics or elements associated with mortality. These might include, for example, the number of cigarettes the now-deceased smoked, their body mass index, or their triglyceride level before they died. The "dying" approach for measuring non-chronological age is also based on a regression process, but the dependent variable, denoted by the familiar $q_{x}$, is a mortality rate, not a chronological age.

More specifically, in this paper the differentiating factor is nationality, using data from the human mortality database (HMD). Just as importantly, the computation of longevity-risk-adjusted global age involves mapping from mortality rates to an assumed age. This is precisely where the GM law of mortality is used. In particular, this paper derives the risk-adjusted age by inverting the GM expression, taking as input both global and local mortality rates and then solving for the implied age $\xi$.

3. Conceptual model: From mortality to age {#sec3}
==========================================

Every adult life in *country* $i$, $i = 1,\ldots,N$, obeys a GM law. The total hazard rate (THR) is: $$\mu_{x}\left\lbrack i \right\rbrack = \lambda\left\lbrack i \right\rbrack + h\left\lbrack i \right\rbrack\, e^{g{\lbrack i\rbrack}\, x},$$where $x \geq 0$ denotes chronological age, $g\left\lbrack i \right\rbrack \geq 0$, is the mortality growth rate (MGR), $h\left\lbrack i \right\rbrack \geq 0$ is the initial *natural* mortality rate (INMR), and $\lambda\left\lbrack i \right\rbrack \geq 0$ is the accidental (non-age-related) hazard rate, a.k.a. Makeham constant. This implies that the log of the THR minus the accidental date rate: $\ln\left\lbrack \mu_{x}\left\lbrack i \right\rbrack - \lambda\left\lbrack i \right\rbrack \right\rbrack$, is a linear function of chronological age $x$, with intercept $\ln\left\lbrack h\left\lbrack i \right\rbrack \right\rbrack$ and slope $g\left\lbrack i \right\rbrack$. Each country $i$ is described by a set: ($\lambda\left\lbrack i \right\rbrack,h\left\lbrack i \right\rbrack$, $g\left\lbrack i \right\rbrack$), which is unique.[6](#fn6){ref-type="fn"}

Moving on, let $\xi\left( x,i \right)$ denote the (new) longevity-risk-adjusted global age for someone at the chronological age of $x$, in country $i$. The manufactured $\xi\left( x,i \right)$ age is also assumed (i.e., forced) to satisfy a GM-like relationship for the hazard rate, inspired by the thick middle line in [Fig. 1](#fig1){ref-type="fig"}. So, every person in country $i$, at the chronological age of $x$, is assumed to have another age denoted by $\xi\left( x,i \right)$, which may -- or may not -- equal their chronological age $x$. The arrows in [Fig. 1](#fig1){ref-type="fig"} go from chronological age to what this paper defines as the longevity-risk-adjusted global age. Formally, the $\xi\left( x,i \right)$ will satisfy: $$\Lambda_{\xi{(x,i)}}\; = \;\Lambda + He^{G\,\xi{(x,i)}},\ln\left\lbrack \Lambda_{\xi{(x,i)}} - \Lambda \right\rbrack\; = \;\ln\left\lbrack H \right\rbrack + G\,\xi\left( x,i \right),$$ where $\Lambda \geq 0$, $H > 0$, and $G \geq 0$ represent the *global* GM parameters. So, if your longevity-risk-adjusted global age $\xi$ increases by one year to $\left( \xi + 1 \right)$, the log hazard rate (minus the Makeham term) grows by $G$ units. The exact procedure by which $\Lambda,H,G$ are estimated will be described later on, but for now one can think of the global values as a *weighted average* of the vector of local values. (Again, see the middle line in [Fig. 1](#fig1){ref-type="fig"} for intuition.) The averaging process, however, cannot be a (trivial) linear average, because the procedure must be consistent with the *compensation law of mortality*.

To our main objective, the longevity-risk-adjusted global (from here on, risk-adjusted) age $\xi ≔ \xi\left( x,i \right)$ in country $i$ is obtained by equating hazard rates at chronological $x$ and solving for the implied $\xi$. Formally: $$\Lambda_{\xi{(x,i)}}\; = \mu_{x}\left\lbrack i \right\rbrack.$$Inverting the GM equation in terms of $\mu_{x}\left\lbrack i \right\rbrack$, will set and determine the L-RaG age $\xi\left( x,i \right)$. Equating [(1)](#fd1){ref-type="disp-formula"}, [(2)](#fd2){ref-type="disp-formula"} results in the very general: $$\xi\left( x,i \right) = \frac{\ln\left\lbrack \lambda\left\lbrack i \right\rbrack - \Lambda + h\left\lbrack i \right\rbrack e^{g{\lbrack i\rbrack}x} \right\rbrack - \ln\left\lbrack H \right\rbrack}{G}.$$

For the above expression to make sense, one must further impose a restriction that $\lambda - \Lambda + h\left\lbrack i \right\rbrack e^{g{\lbrack i\rbrack}x} > 0$, for all country values of $i$ --- which, as long as $x$ is large enough (remember: adult ages), should not pose a problem. From this point of view, Eq. [(4)](#fd4){ref-type="disp-formula"} is the main equation in the paper and the remainder is merely implementation. Eq. [(4)](#fd4){ref-type="disp-formula"} maps a chronological $x$, the country Gompertz--Makeham parameters ($\lambda\left\lbrack i \right\rbrack,h\left\lbrack i \right\rbrack,g\left\lbrack i \right\rbrack$) and the global Gompertz--Makeham parameters $\left( \Lambda,H,G \right)$ into a risk-adjusted age.

To obtain some intuition for Eq. [(4)](#fd4){ref-type="disp-formula"}, assume that in a particular country $i$, and within the Gompertzian age range, the Makeham constant $\lambda\left\lbrack i \right\rbrack = \Lambda$, which is the global Makeham parameter. (In general, however, we will not make that assumption.) In that case, Eq. [(4)](#fd4){ref-type="disp-formula"} can be expressed as: $$\xi\left( x,i \right) = \left( \frac{\ln\left\lbrack h\left\lbrack i \right\rbrack\slash H \right\rbrack}{G} \right) + \left( \frac{g\left\lbrack i \right\rbrack}{G} \right)\, x.$$Intuitively, in Eq. [(5)](#fd5){ref-type="disp-formula"}, the global risk-adjusted age $\xi$, collapses to chronological age $x$ when the country-specific initial natural mortality rate (INMR) is equal to the global average value, and the local mortality growth rate (MGR) is equal to the global average value. Eq. [(5)](#fd5){ref-type="disp-formula"} also indicates that when $g = G$ and the MGR values are equal, but $h \neq H$, the risk-adjusted age $\xi$ is a linear shift (a.k.a. the popular age set-back) of the chronological age $x$, by: $\left. \ln\left\lbrack h\left\lbrack i \right\rbrack\slash H \right\rbrack\slash G \right.$ years. The age set-back approach is common in actuarial practice to model sub-standard or healthy lives, but is technically inconsistent with the *compensation law of mortality*. Here is an example. Assume that in Mauritius ($\lambda\left\lbrack i \right\rbrack = \Lambda$, and) the value of $h\left\lbrack i \right\rbrack$, which is the INMR, is: $15 \times 10^{- 5}$ and the value of $g\left\lbrack i \right\rbrack$ is 0.06; that is, a 6% MGR. According to the compensation law, high values of $h$ are associated with lower values of $g$, and vice versa. So, assume global averages: $H = 1 \times 10^{- 5}$ and $G = 0.09$, both of which are completely fictitious. Under these values an $x = 65$-year-old in Mauritius, according to Eq. [(5)](#fd5){ref-type="disp-formula"}, has a risk-adjusted age of: $\xi = 73.4$; much older than their chronological age.

3.1. In sum: Two regressions and an inversion {#sec3.1}
---------------------------------------------

1.The process starts with vectors of country-specific decrements $q_{x}\left\lbrack i \right\rbrack$, obtained from period mortality tables. They are converted to continuous total hazard rates $\mu_{x}\left\lbrack i \right\rbrack$ in a manner consistent with the Gompertz--Makeham law, since $\mu_{x} \neq q_{x}$.2.Standard linear regression techniques are used to estimate the local Gompertz--Makeham parameters $\left( \lambda\left\lbrack i \right\rbrack,h\left\lbrack i \right\rbrack,g\left\lbrack i \right\rbrack \right)$ for each one of the $i$ countries.3.With the $N$ parameters, a second phase regression is implemented to estimate the global (i.e., average) values of: $\Lambda,H,G$, consistent with a compensation law.4.Longevity-risk-adjusted global ages are computed using Eq. [(4)](#fd4){ref-type="disp-formula"}, using the country-specific: $\left( \lambda\left\lbrack i \right\rbrack,h\left\lbrack i \right\rbrack,g\left\lbrack i \right\rbrack \right)$, and particular values of $\Lambda,H,G$. (In the end I will offer one further simplification that will reduce the number of required parameters, eliminating the $H$, but that will be explained in due time.)

Before moving on to implement each one of the steps in detail, here is a brief recap of the mortality terminology. The model is formulated in continuous time, where the total hazard rate (THR) $\mu_{x}\left\lbrack i \right\rbrack$, at chronological age $x$, in country $i$, is the sum of the accidental (Makeham death) rate $\lambda\left\lbrack i \right\rbrack$ and the natural age-dependent mortality (Gompertz) rate $h\left\lbrack i \right\rbrack e^{g{\lbrack i\rbrack}x}$.

The country-specific parameter $h\left\lbrack i \right\rbrack$ is the initial (age zero) natural mortality rate, a.k.a. INMR, and $g\left\lbrack i \right\rbrack$ is the country-specific mortality growth rate, MGR. To be very clear, despite the term *initial*, $h\left\lbrack i \right\rbrack$ is not the infant mortality rate in country $i$. (The first 30 years of life do not obey the Gompertz law.) Rather, $h\left\lbrack i \right\rbrack$ is a *hypothetical* value that assumes the GM regime extends to age zero. In [Fig. 1](#fig1){ref-type="fig"} it is the point at which the various country-lines hit the $y$-axis, if the $x$-axis is extended leftwards to zero. On the other side, the natural (Gompertz) portion plateaus at chronological age $x^{\ast}$, which is a fixed global parameter, at a value of $\lambda^{\ast}$.

4. The detailed procedure {#sec4}
=========================

As explained, here are the four steps.[7](#fn7){ref-type="fn"}

4.1. Step one: Estimating country GM parameters {#sec4.1}
-----------------------------------------------

Every country is identified and summarized by **3** local plus **2** global = **5** total parameters. They are: {$h\left\lbrack i \right\rbrack,\lambda\left\lbrack i \right\rbrack,g\left\lbrack i \right\rbrack,x^{\ast},\lambda^{\ast}$}, where $i = 1,\ldots,N$, is the number of countries. Note that some countries are estimated to have (very) high accidental death rates (e.g., males in Russia, in [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}a) and other countries have negligible (estimated) accidental death rate (e.g., males in Israel, in [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}). The third term which differentiates one country from another is $g\left\lbrack i \right\rbrack$, which is the corresponding MGR during the *Gompertzian* range of life $x < x^{\ast}$. For those more familiar with the $\left( m,b \right)$ representation of the GM law, it is the country-specific value of the inverse of the dispersion parameter $\left. g = 1\slash b \right.$.

The fourth parameter is global (i.e., not country-specific) and is denoted by $x^{\ast}$. This is the critical age at which the *Gompertzian* regime ends, and is also known as the species-specific lifespan, per [@b19]. In [Fig. 1](#fig1){ref-type="fig"}, it is pictured as the chronological age (approximately $x = 105$) at which the disparate (log) rates intersect and plateau to a constant. This parameter is also estimated from the collection of country rates.

Finally, the (log) natural rates plateau at a fifth estimated parameter value: $\lambda^{\ast}$. If-and-when individuals reach that advanced rate, they face a constant hazard rate (which is country-dependent) and therefore an exponentially distributed remaining lifetime from that point onward. Note that although: $\ln\left\lbrack \mu_{x}\left\lbrack i \right\rbrack - \lambda\left\lbrack i \right\rbrack \right\rbrack$ (y-axis in [Fig. 1](#fig1){ref-type="fig"}) plateaus at a value of $\lambda^{\ast}$, which is constant across all countries, the country-specific total hazard rates will plateau at: $\lambda\left\lbrack i \right\rbrack + \lambda^{\ast}$, after age $x^{\ast}$. The THR $\mu_{x}$, will obey the following relationship: $$\mu_{x}\left\lbrack i \right\rbrack - \lambda\left\lbrack i \right\rbrack = \left\{ \begin{array}{cl}
{h\left\lbrack i \right\rbrack e^{g{\lbrack i\rbrack}x}} & {x < x^{\ast}} \\
\lambda^{\ast} & {x \geq x^{\ast}.} \\
\end{array} \right)$$Empirically, the plateau mortality rate: $\lambda^{\ast} \gg \lambda\left\lbrack i \right\rbrack$ and the corresponding age $x^{\ast}$, is a global constant, as per the strict version of the *compensation law of mortality.* Nevertheless, it is worth emphasizing that Eq. [(6)](#fd6){ref-type="disp-formula"} is quite general, as it is conceivable that $\left. x^{\ast}\rightarrow\infty \right.$. Rearranging, the model can be expressed as: $$\overset{Q_{x}}{\overset{︷}{\,\ln\left( \mu_{x}\left\lbrack i \right\rbrack\; - \lambda\left\lbrack i \right\rbrack \right)\,}} = \overset{C_{0}}{\overset{︷}{\,\ln h\left\lbrack i \right\rbrack\,}} + \overset{C_{1}}{\overset{︷}{g\left\lbrack i \right\rbrack}}x,\;\;\;\forall\, x < x^{\ast},$$which is the standard linear representation of (log) total hazard minus accidental death rates for all ages within the GM regime. A deliberate choice is made to use $Q_{x}$, on top of the brace, and not the natural log of the one-year death rate $\ln\left\lbrack q_{x} \right\rbrack$, because $q_{x}$ and $\mu_{x}$ are not the same quantity. Although the two numbers are close for small values of $q_{x}$, in continuous time the total hazard rates can (obviously) exceed the value of one.[8](#fn8){ref-type="fn"}

Recall that $q_{x}$, at any given age $x$, is related to the total hazard rate $\mu_{x}$, via: $$1 - q_{x} = e^{- \int_{x}^{x + 1}\mu_{y}dy}.$$Now, when $\mu_{x} = \lambda$, is constant (i.e., $h = 0$), the survival rate to any time $t$ is $e^{- \lambda t}$, and then $q_{x} = 1 - e^{- \lambda}$, for any one year. In this (simplistic, clearly non-Gompertz) case, the $\mu_{x}$ is synonymous with a *continuously* compounded mortality rate and $q_{x}$ is the *effective* annual (one-year) death rate. In the full Gompertz--Makeham ($h > 0$) case, Eq. [(8)](#fd8){ref-type="disp-formula"} leads to the following relationship between $q_{x}$ and the model parameters $\left( \lambda,h,g \right)$: $$\left. - \ln\left\lbrack 1 - q_{x} \right\rbrack = \lambda + he^{gx}\left( {e^{g} - 1} \right)\slash g \right.$$Note that by definition: $- \ln\left\lbrack 1 - q_{x} \right\rbrack > \lambda \geq 0$, so one can subtract the accidental death (Makeham) rate $\lambda$ from both sides of the above expression, take logs (again) and obtain a linear relationship between the (transformed value of the) one-year decrement $q_{x}$ and chronological age $x$. The relationship can be written explicitly for each of the groups as: $$\overset{z}{\overset{︷}{\ln\left( {\ln\left( \frac{1}{1 - q_{x}\left\lbrack i \right\rbrack} \right) - \lambda\left\lbrack i \right\rbrack} \right)}}\; = \;\overset{K_{0}}{\overset{︷}{\ln\left\lbrack h\left\lbrack i \right\rbrack \right\rbrack\, + \,\ln\left\lbrack \left( e^{g{\lbrack i\rbrack}} - 1 \right)\slash g\left\lbrack i \right\rbrack \right\rbrack}}\;\quad + \,\overset{K_{1}}{\overset{︷}{g\left\lbrack i \right\rbrack}}\, x.$$ The new constants $\left( K_{0},K_{1} \right)$ are defined for convenience and suggest the proper regression methodology for calibrating GM parameter values of $\lambda,h,g$ from one-year decrement rates $q_{x}$. To be very clear, $\ln\left\lbrack \ln\left\lbrack \left( 1 - q \right)^{- 1} \right\rbrack \right\rbrack \approx \ln\left\lbrack q \right\rbrack$ for small values of $q$, so the approximation (that some researchers employ, in treating $q_{x}$ and $\mu_{x}$ as the same) is justified. But errors are introduced when $\lambda\left\lbrack i \right\rbrack \neq 0$ and/or when $q_{x}\left\lbrack i \right\rbrack \gg 0$. At the very least, if one insists on using Eq. [(7)](#fd7){ref-type="disp-formula"} instead of Eq. [(10)](#fd10){ref-type="disp-formula"} to estimate Gompertz--Makeham parameters, it is more accurate to use $\left. \ln\left\lbrack q \right\rbrack + q\slash 2 \right.$ as the dependent variable to match the first two terms of the Taylor series expansion.[9](#fn9){ref-type="fn"} For now, this leads to the GM regression equation: $$z_{i,j} = K_{0}\, + \, K_{1}x_{j} + \,\epsilon_{i,j},$$where $x_{j}$ is a vector of ages, for example $x_{1} = 35,x_{2} = 36,x_{3} = 37$, etc., and the $z_{i,j}$ are computed from the one-year mortality decrements $q_{x}$ in country $i$. Eq. [(11)](#fd11){ref-type="disp-formula"} embeds an implicit assumption that the error terms $\epsilon_{i,j}$, are independent across chronological age $x$ and across countries $i$. The robustness of this assumption is discussed in Section [5.1](#sec5.1){ref-type="sec"}. See [Fig. 2](#fig2){ref-type="fig"} for a graphic visualization of the full data used in this phase.

Note that to properly estimate the accidental (Makeham) death rate $\lambda\left\lbrack i \right\rbrack$, in each country $i$, an iterative procedure was used. Initially, $\lambda\left\lbrack i \right\rbrack$ is assumed to be zero and a basic canonical regression is estimated, per Eq. [(10)](#fd10){ref-type="disp-formula"}. The value of $\lambda\left\lbrack i \right\rbrack$ is gradually increased by units of 10^−5^, and iterated (i.e., searched for) until the GM regression error is minimized. The upper bound (in the search for) $\lambda\left\lbrack i \right\rbrack$, is $\mu\left\lbrack i \right\rbrack$, since the accidental death rate cannot be higher than the total death rate over the GM region.[10](#fn10){ref-type="fn"} Fig. 2One-year mortality decrements around the world. Note: Raw one-year decrement $q_{x}$ data used in the first phase regression, from 38 countries (male and female) in the Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). Available at www.mortality.org or www.humanmortality.de (last accessed on 15/Jan/2020).

Minutiae aside, once the unique and group-specific values for $\lambda\left\lbrack i \right\rbrack$ are located, the associated regression formulated in Eq. [(11)](#fd11){ref-type="disp-formula"} leads to the best-fitting intercept and slope parameters ${\overset{\sim}{K}}_{0}$ and ${\overset{\sim}{K}}_{1}$. More importantly, based on Eq. [(10)](#fd10){ref-type="disp-formula"}, the unbiased estimates for the GM parameters for each one of the groups, are: $$g\left\lbrack i \right\rbrack = \overset{\sim}{K_{1}},\ln\left\lbrack h\left\lbrack i \right\rbrack \right\rbrack = \overset{\sim}{K_{0}} - \ln\left\lbrack \left( e^{\overset{\sim}{K_{1}}} - 1 \right)\slash\overset{\sim}{K_{1}} \right\rbrack,$$$$h\left\lbrack i \right\rbrack = \overset{\sim}{K_{1}}e^{\overset{\sim}{K_{0}}}\left( {e^{\overset{\sim}{K_{1}}} - 1} \right)^{- 1}$$ These are (i.) the natural mortality growth rate, (ii.) the log initial natural mortality rate, and (iii.) the natural initial mortality rate at age zero, for each $i$. This process is referred to as the first-phase regression, although in reality each group-set of $h\left\lbrack i \right\rbrack,g\left\lbrack i \right\rbrack$ values requires multiple regressions until the error-minimizing value of $\lambda\left\lbrack i \right\rbrack$ is located.

As noted in the introduction, researchers in actuarial finance (and in particular the annuity literature) might be more accustomed to the probabilistic formulation of the Gompertz--Makeham law in terms of the modal value $m$ and dispersion coefficient $b$ of the remaining lifetime random variable. Using that formulation, the total hazard rate $\mu_{x}$ is expressed as: $\lambda + \left( 1\slash b \right)e^{{(x - m)} \slash b}$. So, the conversion from estimates of $\left( h,g \right)$ to estimates of $\left( m,b \right)$ would be via $\left. b = 1\slash g \right.$ and $\left. m = \left( \ln\left\lbrack g \right\rbrack - \ln\left\lbrack h \right\rbrack \right)\slash g \right.$. Either way, both the $\left( h,g \right)$ and $\left( m,b \right)$ parameter estimates are displayed in [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}, for all available countries in the Human Mortality Database.

Now, in theory, one could stop (the estimation procedure) here and compute arithmetic or geometric (or some other harmonic) average global value for $\Lambda,H,G$ and then use those with the individual values of $\lambda\left\lbrack i \right\rbrack,h\left\lbrack i \right\rbrack,g\left\lbrack i \right\rbrack$ to compute longevity-risk-adjusted global ages via Eq. [(4)](#fd4){ref-type="disp-formula"}. However, this would very critically ignore the fact that (i.) the sum of Gompertz variates is not Gompertz, and more importantly, it would be inconsistent with (ii.) the *compensation law of mortality* which forces a strict relationship between $h$ and $g$. The expression for longevity-risk-adjusted ages described in the next section will account for both.

Table 2Compensation law regression line around the world.VariableMALEFEMALECoeff.Std.Ert-val.Coeff.Std.Ert-val.Intercept $\left( L \right)$−0.9420.184−5.116−1.2640.679−1.861Slope: $\left( - x^{\ast} \right)$**−98.033**1.924−50.944**−97.211**6.342−15.329Adj. $R^{2}$98.59%86.35%Range: $g\left\lbrack i \right\rbrack$$\left( 6.90\text{\%},11.07\text{\%} \right)$$\left( 9.56\text{\%},12.27\text{\%} \right)$Average: $g\left\lbrack i \right\rbrack$G $=$$9.50\text{\%}\text{\%}$G $=$$10.70\text{\%}\text{\%}$Plateau (＋/−): $\lambda^{\ast}$$\left( 0.270,0.564 \right)$$\left( 0.073,1.099 \right)$Countries$N = 38$$N = 38$[^1]HMD, Period Tables 2011 (Last accessed 15/Jan/2020).

4.2. Step two: Including clam {#sec4.2}
-----------------------------

The weak form of the *compensation law of mortality* states that groups with relatively higher initial mortality hazard rates: $h\left\lbrack i \right\rbrack > h\left\lbrack j \right\rbrack$, experience relatively lower mortality growth rates $g\left\lbrack i \right\rbrack < g\left\lbrack j \right\rbrack$, and vice versa. In other words, *compensation* posits a formal analytic relationship between $h\left\lbrack i \right\rbrack$ and $g\left\lbrack i \right\rbrack$, denoted by $\overset{\rightarrow}{h}\left( g \right)$, within a range of: $g_{\mathtt{\min}} \leq g \leq g_{\mathtt{\max}}$. In some sense, while the classical Gompertz law allows for two degrees of freedom -- the slope and intercept of the log hazard line -- *compensation* stipulates that once the slope is known, the intercept is pre-determined. There is only one (real) degree of freedom in mortality, a fact which has recently been pointed out and leveraged by [@b43] in the context of fitting the Gompertz law using Hermite splines. To be clear though, the weak-form compensation law stipulates that: $\left. \partial\overset{\rightarrow}{h}\left( g \right)\slash\partial g < 0 \right.$, if one thinks of $h$ as a function of $g$. In contrast to the weak form, a strong form compensation law begins at the very end of the lifecycle by postulating that the natural mortality plateau is identical for all sub-groups. This actually places much tighter restrictions on the function $\overset{\rightarrow}{h}\left( g \right)$, and by Eq. [(6)](#fd6){ref-type="disp-formula"} implies: $$L\; ≔ \;\ln\left( \lambda^{\ast} \right) = \ln\overset{\rightarrow}{h}\left( g \right) + gx^{\ast}.$$The $L = \ln\left\lbrack \lambda^{\ast} \right\rbrack$ is introduced as a convenient intercept constant. Rearranging Eq. [(13)](#fd13){ref-type="disp-formula"} leads to a linear representation for the function: $\ln\overset{\rightarrow}{h}\left( g \right)$, and can be expressed as: $$\ln\overset{\rightarrow}{h}\left( g \right) = L\; - x^{\ast}\, g,$$In what follows, $\ln\overset{\rightarrow}{h}\left( g \right)$ is referred to as the *compensation* line mapping a specific initial mortality growth rate $g$ to a corresponding log natural mortality rate $\ln\overset{\rightarrow}{h}\left( g \right)$. Exponentiating Eq. [(14)](#fd14){ref-type="disp-formula"}, the initial natural mortality rate: $\overset{\rightarrow}{h}\left( g \right)$ can be expressed as: $\overset{\rightarrow}{h}\left( g \right) = e^{L - x^{\ast}g}$, which at $g = 0$ recovers the mortality plateau: $\lambda^{\ast} = \overset{\rightarrow}{h}\left( 0 \right)$. Either way, it follows that under the strong *compensation law*, one can rewrite the total hazard rate $\mu_{x}$, from Eq. [(6)](#fd6){ref-type="disp-formula"} as: $${\overset{\rightarrow}{\mu}}_{x}\left( g \right)\left\lbrack i \right\rbrack = \left\{ \begin{array}{cl}
{\lambda\left\lbrack i \right\rbrack + \lambda^{\ast}e^{g{(x - x^{\ast})}}} & {x < x^{\ast}} \\
{\lambda\left\lbrack i \right\rbrack + \lambda^{\ast}} & {x \geq x^{\ast},} \\
\end{array} \right)$$which could also be expressed[11](#fn11){ref-type="fn"} in terms of $\left( m,b \right)$. The function ${\overset{\rightarrow}{\mu}}_{x}\left( g \right)\left\lbrack i \right\rbrack$, which, at first, might seem cumbersome is meant to remind readers of a number of implicit assumptions from this point onward. First, under a strict compensation law, the initial natural mortality rate is driven and dictated (only) by the mortality growth rate: that is the only degree of mortality freedom per country, other than the accidental death (Makeham-constant) rate $\lambda\left\lbrack i \right\rbrack$. Secondly, although the natural mortality rate plateaus at a global value of $\lambda^{\ast}$, the country-specific *total* plateau must also account for the accidental rate $\lambda\left\lbrack i \right\rbrack$, which is why both are added together in the lower branch of Eq. [(15)](#fd15){ref-type="disp-formula"}. Procedurally, only the $N$ country-specific values of $\left\{ \ln h\left\lbrack i \right\rbrack,\lambda,g\left\lbrack i \right\rbrack \right\}$, are needed. These are used to estimate the (intercept) $L$, and (slope) $x^{\ast}$ via a second regression. Per Eq. [(14)](#fd14){ref-type="disp-formula"}, the relationship is: $$\overset{w_{j}}{\overset{︷}{\;\ln h\left\lbrack i \right\rbrack\;}} = \overset{C_{0}}{\overset{︷}{L}}\; + \;\overset{C_{1}}{\overset{︷}{\left( - x^{\ast} \right)}}\, g\left\lbrack i \right\rbrack\, + \epsilon_{j},$$where the error terms $\epsilon_{j}$, are distinct from the error terms in Eq. [(10)](#fd10){ref-type="disp-formula"}. See Section [5.1](#sec5.1){ref-type="sec"} for some addition robustness details, but the second phase regression cannot be merged with the first phase regression used to estimate the original GM parameters in Eq. [(10)](#fd10){ref-type="disp-formula"}, because of the need to (i.) iteratively estimate and then (ii) subtract the country-specific accidental death rates $\lambda\left\lbrack i \right\rbrack$. Also, the first regression generates the: $\ln h\left\lbrack i \right\rbrack,\lambda\left\lbrack i \right\rbrack$ and $g\left\lbrack i \right\rbrack$ values in [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}, which might be of independent use and interest to researchers who use this law for pricing annuities or modeling retirement strategies, as cited in footnote 1.

[Table 2](#tbl2){ref-type="table"} displays the estimated values using the individual GM parameters, which effectively test for the presence of strong compensation in the data. Indeed, the relationship between: $\ln h\left\lbrack i \right\rbrack$ and $g\left\lbrack i \right\rbrack$ is linear with very high $R^{2}$ values, providing support for a strong version CLaM for the $N = 38$ countries. Finally, the estimated $L = \ln\left( \lambda^{\ast} \right)$, locates the natural mortality rate at the plateau. The slope $\left( - x^{\ast} \right)$ is the age at which it is achieved, a.k.a. the *species specific lifespan*. See [Fig. 3](#fig3){ref-type="fig"} for a visual indication of the strong negative relationship between the two variables on a country-by-country basis.

Fig. 3Growth rates $g$, versus (log) initial natural mortality rates $\ln\left\lbrack h \right\rbrack$, around the world. Note: There is a negative relationship between the mortality growth rate $g\left\lbrack i \right\rbrack$ in a given country, and the (log) of initial natural mortality rate $\ln\left\lbrack h\left\lbrack i \right\rbrack \right\rbrack$. This is consistent with the *compensation law of mortality*, central to the procedure used to compute longevity-risk-adjusted global ages. The estimated slope and intercept values are displayed in [Table 2](#tbl2){ref-type="table"}.

4.3. Stage three: Baseline population rates {#sec4.3}
-------------------------------------------

We now have a set of diverse GM parameters as well as (one, global pair) $\left( \lambda^{\ast},x^{\ast} \right)$. Back to the computation of longevity-risk-adjusted age: the next step is to compute population averages $\Lambda,H,G$ values, to then invert the GM equation and map one-year decrements into $\xi\left( x,i \right)$, as per Eq. [(4)](#fd4){ref-type="disp-formula"}. By this point in the narrative it should be clear that one cannot average *both* the individual $h\left\lbrack i \right\rbrack$ *and* the individual $g\left\lbrack i \right\rbrack$ values estimated in phase one. Once again, there is only one degree of freedom according to the compensation law. Rather, the suggested and proposed way to obtain the required global GM parameters is to locate the implied $h\left\lbrack i \right\rbrack$ in a manner consistent with compensation for that country's particular natural mortality growth rate $g\left\lbrack i \right\rbrack$. Accordingly, the next step is to average the mortality growth rates $g\left\lbrack i \right\rbrack$, to arrive at global value of $G$ and then use the compensation line to obtain an implied $H$.

4.4. Stage four: Computing longevity-risk-adjusted global ages {#sec4.4}
--------------------------------------------------------------

The risk-adjusted age: $\xi\left( x,i \right)$, of someone whose chronological age is $x$ in country $i$, is constructed by equating mortality hazard rates per Eq. [(3)](#fd3){ref-type="disp-formula"}. Per the compensation law, we proceed by assuming the total hazard rate is classified entirely by the country-specific mortality growth rate $g$ and the country-specific accidental death rate $\lambda$, so there is no need to explicitly include the initial natural mortality rate $h$. In particular, the definition $\xi\left( x,i \right)$ from Eq. [(3)](#fd3){ref-type="disp-formula"}, can now be written as: $${\overset{\rightarrow}{\mu}}_{\xi{(x,i)}}\left( G,\Lambda \right) = {\overset{\rightarrow}{\mu}}_{x}\left( g\left\lbrack i \right\rbrack,\lambda\left\lbrack i \right\rbrack \right).$$To be clear, the only parameters required at this point are the mortality growth rate $g\left\lbrack i \right\rbrack$, the accidental death (Makeham-constant) rate $\lambda\left\lbrack i \right\rbrack$, and the respective global averages $G$, and $\Lambda$, as well as the global plateau age $x^{\ast}$ and natural plateau mortality rate $\lambda^{\ast}$. As to the global averages, they are defined arithmetically: $$G\; = \;\frac{1}{N}\sum\limits_{i = 1}^{N}g\left\lbrack i \right\rbrack$$$$\Lambda\; = \;\frac{1}{N}\sum\limits_{i = 1}^{N}\lambda\left\lbrack i \right\rbrack,$$ which will be discussed in Section [5.1](#sec5.1){ref-type="sec"}. For now, referring back to the formulation expressed in Eq. [(15)](#fd15){ref-type="disp-formula"}, the next step is to eliminate some redundant terms.

Recall that the equation for $\xi\left( x,i \right)$ is designed to equate total hazard rates, so: $$\Lambda + \lambda^{\ast}e^{G{(\xi{(x,i)} - x^{\ast})}}\; = \;\lambda\left\lbrack i \right\rbrack + \lambda^{\ast}e^{g{\lbrack i\rbrack}{(x - x^{\ast})}},\;\;\; x \leq x^{\ast}$$The objective now is to isolate $\xi\left( x,i \right)$ as a function of the (estimated) country-specific and global parameters. After dividing both sides of the above equation by $\lambda^{\ast} > 0$, the relevant equality can be re-written as: $$\left( \frac{\Lambda - \lambda\left\lbrack i \right\rbrack}{\lambda^{\ast}} \right) = e^{g{\lbrack i\rbrack}{(x - x^{\ast})}}\; - \; e^{G{(\xi{(x,i)} - x^{\ast})}}.$$In words, if the *global* total hazard rate at age $\xi\left( x,i \right)$ is equal to the *local* total hazard rate at age $x$, then the relationship between $\xi\left( x,i \right)$ and $x$, per Eq. [(20)](#fd20){ref-type="disp-formula"}, must satisfy: $$e^{g{\lbrack i\rbrack}x + {(G - g{\lbrack i\rbrack})}x^{\ast}}\; - \;\left( \frac{\Lambda - \lambda\left\lbrack i \right\rbrack}{\lambda^{\ast}} \right)e^{Gx^{\ast}} = e^{G\xi{(x,i)}}.$$This expression is valid as long as the left-hand side is positive which (it is, and) will be justified in a moment. This then leads to the following expression for $\xi$ as a function of $x$, and the key parameters: $$\xi\left( x,i \right) = x^{\ast}\; + \;\frac{1}{G}\,\ln\left\lbrack {e^{g{\lbrack i\rbrack}{(x - x^{\ast})}} - \left( \frac{\Lambda - \lambda\left\lbrack i \right\rbrack}{\lambda^{\ast}} \right)} \right\rbrack.$$This expression only makes sense, or is properly defined, if the quantity: $\left. \left( \Lambda - \lambda\left\lbrack i \right\rbrack \right)\slash\left( \lambda^{\ast} \right) \right.$ is smaller than $e^{g{\lbrack i\rbrack}{(x - x^{\ast})}}$. If not, the argument within the logarithm becomes negative. But, considering that $\Lambda$ and $\lambda\left\lbrack i \right\rbrack$ are on the order of 10^−5^, and $e^{g{\lbrack i\rbrack}{(x - x^{\ast})}}$ is many multiples greater, in practice this is a non-issue, especially over the adult-age ($x \geq 35$) range. In fact, $\left. \left( \Lambda - \lambda\left\lbrack i \right\rbrack \right)\slash\left( \lambda^{\ast} \right) \right.$ itself is very close to zero.

Effectively, we are done. Eq. [(21)](#fd21){ref-type="disp-formula"} is the proper formula for $\xi$. It maps a *local* chronological age $x$, in country $i$, into a longevity-risk-adjusted *global* age $\xi$. There are no approximations or assumptions made at this point, other than the (i.) Gompertz--Makeham law, and (ii.) the compensation law of mortality.

However, we can push this further by exploiting the relatively small (or near-zero) value of the constant within the logarithm: $\left. \left( \Lambda - \lambda\left\lbrack i \right\rbrack \right)\slash\left( \lambda^{\ast} \right) \right.$, in Eq. [(21)](#fd21){ref-type="disp-formula"}. It is possible to create a restricted and more compact version of Eq. [(21)](#fd21){ref-type="disp-formula"}, similar to the one presented at the very beginning of this section. Namely, $\xi\left( x,i \right)$ can be approximated by: $$\xi\left( x,i \right)\; \approx \; x^{\ast}\; + \frac{g\left\lbrack i \right\rbrack}{G}\left( x - x^{\ast} \right) = x - \kappa\left\lbrack i \right\rbrack\left( x^{\ast} - x \right),$$where the newly defined constant: $\kappa\left\lbrack i \right\rbrack = \left( g\left\lbrack i \right\rbrack\slash G \right) - 1$, is the *relative* aging rate. Although this is an approximation, the loss or error from ignoring $\left. \left( \Lambda - \lambda\left\lbrack i \right\rbrack \right)\slash\left( \lambda^{\ast} \right) \right.$ is on the order of a few months. Under the approximation, the longevity-risk-adjusted age is expressed (only) as a function of (1.) the relative aging rate $\kappa$, and (2.) the species-specific lifespan $x^{\ast}$. And, if the mortality growth rate $g\left\lbrack i \right\rbrack = G$, which is the global average rate, then $\xi\left( x,i \right) = x$, the chronological age. All of these are (expected and) consistent with intuition.

Here is a numerical example using the approximate expression for $\xi$, in [(22)](#fd22){ref-type="disp-formula"}. Assume the mortality plateau occurs at age: $x^{\ast} = 110$, chronological age is: $x = 50$, the natural mortality growth rate in country $i$ is: $g\left\lbrack i \right\rbrack = 10\text{\%}$, and the global average mortality growth rate is: $G = 9\text{\%}$, in which case the relative aging rate is: $\left. \kappa_{i} = 11.11\text{\%} = 1\slash 9 \right.$. For these parameters, the estimated longevity-risk-adjusted global age is: $\left. \xi = 50 - \left( 110 - 50 \right)\slash 9 = 43\frac{1}{3} \right.$. This individual's longevity-risk-adjusted global age is 6.66 years less than their chronological age. Remember, the mortality rates are embedded implicitly in $x^{\ast}$.

Now, it is an open empirical question as to what happens after the species-specific lifespan $x^{\ast}$, and whether the (log) curve is constant in [Fig. 1](#fig1){ref-type="fig"} after age $x^{\ast}$. But, as modeled, it is assumed that from that age onward the *the total hazard rate is constant*, which once again implies that conditional lifetimes are exponentially distributed after they reach a chronological age of $x^{\ast}$. The framework assumes no crossover in log-mortality rates.[12](#fn12){ref-type="fn"} And, all else being equal, a larger value of $x^{\ast}$ lowers $\xi$, and the same is true for larger values of $\kappa\left\lbrack i \right\rbrack$.

Indeed, it is worth emphasizing that when the value of $\kappa\left\lbrack i \right\rbrack > 0$, aging for that group (i.e., country) is faster than average ($g\left\lbrack i \right\rbrack > G$), and yet the longevity-risk-adjusted global age, $\xi\left( x,i \right)$ is lower than chronological age, $x$. This might seem odd at first, but is driven by the *compensation law of mortality* which underlies Eq. [(22)](#fd22){ref-type="disp-formula"}. Note that a value of $g\left\lbrack i \right\rbrack > G$, is associated with an initial natural mortality rate: $\overset{\rightarrow}{h}\left( g\left\lbrack i \right\rbrack \right) < \overset{\rightarrow}{h}\left( G \right)$, where $\overset{\rightarrow}{h}\left( . \right)$ is expressed as a function of the group's mortality growth rate. Stated graphically, this person is on a lower curve within [Fig. 1](#fig1){ref-type="fig"}, so they are deemed to be younger. All else being equal, an individual with a lower longevity-risk-adjusted global age -- which means they have a lower-than-global-average total hazard rate -- ages faster.Table 3Longevity Risk-adjusted global ages $\left( \xi \right)$ around the world.CountryMALEFEMALE$x = 55$$x = 70$$x = 85$$x = 55$$x = 70$$x = 85$1. Australia49.5866.0083.0953.5568.9884.532. Austria52.6568.6884.4153.9969.6784.893. Belarus66.6577.6388.5558.8572.1085.904. Belgium53.0468.8084.4555.9570.7785.365. Bulgaria57.5971.8185.8655.1569.7784.866. Canada51.5867.7283.9355.7370.5785.277. Croatia54.2369.6884.8752.6668.8984.548. Czechia54.1169.6084.8452.8168.7384.459. Denmark52.6568.6584.3954.6670.0985.0810. Estonia60.3973.6086.6957.6671.8285.8311. Finland54.5569.7384.8754.6970.0385.0412. France56.4370.9585.4457.3071.5485.7013. Germany52.6768.7084.4254.1469.6784.8814. Greece55.1970.2585.1351.4367.7283.9815. Hungary58.2172.2186.0457.3971.7785.8216. Ireland50.6867.1083.6454.9270.1985.1117. Israel52.1068.3484.2652.1268.2084.2018. Italy49.0666.2583.2752.1668.3684.2919. Japan51.6067.7283.9354.7869.6884.8420. Korea53.1468.7784.4249.9966.2083.2421. Latvia63.3275.4887.5659.2672.8486.2922. Lithuania65.5476.9188.2259.6872.9286.3023. Luxembourg49.1266.4883.4054.0369.7284.9124. Netherlands48.6866.0883.2055.3570.4285.2125. New Zealand50.5266.9083.5454.1969.3884.7126. Norway49.5166.4183.3353.7169.4984.8127. Poland60.3273.5586.6656.3971.1085.5228. Portugal55.7670.4785.2153.4168.9784.5429. Russia66.6877.3088.3559.2671.5985.5530. Slovakia57.2471.5985.7654.2969.8284.9531. Slovenia53.5369.2384.6754.5270.0185.0432. Spain52.8468.8084.4753.4169.1284.6233. Sweden47.6865.3382.8452.0768.4084.3134. Switzerland48.9966.1583.2253.0769.0684.6135. Taiwan59.3072.5586.1554.4569.4584.7336. U.K.51.3567.2983.7055.1670.0885.0437. U.S.A.56.9971.1585.5258.9172.4286.0738. Ukraine64.2475.7587.6457.3070.3685.02**Average:557085557085***HMD, Period Tables 2011 (Last accessed 15/Jan/2020)*.

A final item to note is that (under the approximate expression) the link between $x$ and $\xi\left( x,i \right)$ does not require explicit knowledge of the current total hazard rate $\mu_{x}\left\lbrack i \right\rbrack$, or the $q_{x}\left\lbrack i \right\rbrack$. That information is embedded in the parameters: $x^{\ast}$, $\kappa\left\lbrack i \right\rbrack$. Of course, the exact expression for $\xi\left( x,i \right)$ in Eq. [(21)](#fd21){ref-type="disp-formula"} would require knowing the value of the accidental death rates $\lambda\left\lbrack i \right\rbrack$ relative to the plateau value $\lambda^{\ast}$. In sum, leveraging a compensation law within the estimation procedure is not only consistent with current theories of aging, per [@b19], but also reduces the number of parameters required to estimate $\xi\left( x,i \right)$.

5. Estimates: Ages around the world {#sec5}
===================================

[Table 3](#tbl3){ref-type="table"} displays numerical results from the methodology described in the prior section, using period mortality rates (between chronological ages $x = 35$ to $x = 95$) for $N = 38$ countries from the human mortality database (HMD) in the year 2011, the most recent year for which the largest and most complete country data is available. Each of the 38 decrement vectors $q_{x}\left\lbrack i \right\rbrack$ was used to iteratively estimate the best-fitting $\left( h\left\lbrack i \right\rbrack,\lambda\left\lbrack i \right\rbrack,g\left\lbrack i \right\rbrack \right)$ values for males and females separately. Those results were displayed and discussed in [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}, noted earlier. The R-squares values and all other summary statistics for goodness of fit are not reported within [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}, because those values were all above 95%. The (very) good fit of the Gompertz--Makeham law of mortality on a country-by-country basis over the (chronological) age range \[35, 95\] is well known in the demographic or actuarial literature, as per [@b50], for a recent example.

With the first-stage regression numbers in hand in [Table 1a](#tbl1a){ref-type="table"}, [Table 1b](#tbl1b){ref-type="table"}, the next step is to estimate the second-phase regression to obtain the best-fitting *compensating law of mortality* line combining the mortality rates of these 38 countries. The estimated (second-phase) regression line is displayed in [Fig. 3](#fig3){ref-type="fig"}, and the parameter estimates are presented in [Table 2](#tbl2){ref-type="table"}. In particular, the estimated male plateauing age was $x^{\ast} \approx 98$ and the female plateauing age was $x^{\ast} \approx 97$. The standard error for those point estimates was approximately 2 years for males and 6 years for females. Likewise, although the R-squared values were quite high (98%) for males, they were lower (86%) for females. Practically speaking, it is entirely plausible the mortality plateau occurs later in life, perhaps even at the age of 110 (or perhaps there is no plateau at all). (Indeed, this is an open question in the bio-demographic literature and arguably outside the scope of this article. See [@b2] for more on this issue.) Either way, these values for $x^{\ast}$, which are required for Eq. [(21)](#fd21){ref-type="disp-formula"}, are used in [Fig. 4](#fig4){ref-type="fig"}, to provide a range for the longevity-risk-adjusted global ages.

For example, an $x = 55$-year-old Russian male has a risk-adjusted age of $\xi = 66.7$, whereas a $x = 55$-year-old Swedish male has an age of $\xi = 47.7$, which is a gap of almost two decades between the youngest and oldest in [Table 3](#tbl3){ref-type="table"}. Using the same equation for females with a unique $g\left\lbrack i \right\rbrack$ and higher $x^{\ast}$, the largest gap at age $x = 55$, is between the Korean whose $\xi = 50$ and the Lithuanian $\xi = 59.7$. The gap for females is slightly less than ten years. This (lower dispersion) is due to the fact that the range of mortality growth rates $g\left\lbrack i \right\rbrack$, are not as wide. Notice also that as one increases the chronological age from $x = 55$ to $x = 70$ and then $x = 85$, the gap between the highest and lowest risk-adjusted age shrinks to zero across the different countries. This, effectively, is the compensation law of mortality in action, as the one-year mortality decrements $q_{x}\left\lbrack i \right\rbrack$ are converging as well. Finally, [Fig. 4](#fig4){ref-type="fig"} (mentioned earlier) displays longevity-risk-adjusted global ages, based on the exact equation for $\xi\left( x,i \right)$.Fig. 4Longevity-risk-adjusted global age at chronological age $55$. Note: The longevity-risk-adjusted global age: $\xi\left( 55,i \right)$, across $N = 38$ countries, is based on the (exact) Eq. [(21)](#fd21){ref-type="disp-formula"}, using global average mortality growth rates $G$, and the plateau age $x^{\ast}$, estimated in the second phase regression (and displayed in [Table 2](#tbl2){ref-type="table"}.) It is important to note that these are point estimates.

5.1. Further discussion of assumptions and robustness {#sec5.1}
-----------------------------------------------------

This paper, and the advocated framework, made a number of simplifying (and perhaps even *ad hoc*) assumptions which at this juncture are worth clarifying and defending. First and foremost, much of what motivates many of the assumptions made was *convenience* --- plus a healthy respect and admiration for the history of the Gompertz law.

Now certainly, the Gompertz law of mortality might be one of the oldest, simplest and best-known laws of mortality, but it certainly is not the only one. One could implement the same inversion with [@b40], [@b3], Weibull or logistic-based Vaupel--Kannisto models, which is on the agenda for further research. And yet, it is worth noting that [@b20] claim: "It was found that for all studied HMD birth cohorts, the Gompertz model demonstrated better fit of mortality data than the Kannisto model in the studied age interval". With that in mind, [Table 4a](#tbl4a){ref-type="table"}, [Table 4b](#tbl4b){ref-type="table"} and [Fig. 5](#fig5){ref-type="fig"} offer a historical view of the GM model to get a sense of how the estimated parameters have evolved over the last 50 years.

Indeed, aggregate mortality has been improving and the global $\Lambda,G$ parameters do change over time and are not universal constants. Along the same lines, the $\Lambda,G$ values were computed via a simple arithmetic average, although they could certainly have been weighted by population size, population wealth or even geographic country size. Another alternative would have been to match life expectancy $E\left\lbrack T_{x} \right\rbrack = E\left\lbrack T_{\xi} \right\rbrack$ instead of hazard rates, or perhaps use (inverted) phase-type laws, similar to [@b29] or [@b22]. All these alternatives are equally valid, but equally questionable.Table 4aGompertz regression: $\left( m,b \right)$ coefficients (＋/−) 2SE.YearDispersion coefficient $m$Modal value $b$MALEFEMALEMALEFEMALE1945**76.86**$\pm 4.20$**80.24**$\pm 2.15$**11.05**$\pm 2.04$**10.20**$\pm 1.76$1948**77.22**$\pm 4.36$**81.11**$\pm 1.76$**11.45**$\pm 1.66$**10.17**$\pm 1.12$1951**76.92**$\pm 4.38$**80.76**$\pm 1.85$**11.02**$\pm 1.57$**9.85**$\pm 1.08$1954**77.68**$\pm 3.34$**81.57**$\pm 1.42$**10.93**$\pm 1.27$**9.82**$\pm 1.00$1957**77.43**$\pm 3.39$**81.68**$\pm 1.53$**10.92**$\pm 1.19$**9.68**$\pm 0.99$1960**77.81**$\pm 3.04$**82.15**$\pm 1.44$**10.78**$\pm 1.27$**9.50**$\pm 0.99$1963**77.51**$\pm 2.92$**82.17**$\pm 1.48$**10.80**$\pm 1.23$**9.51**$\pm 0.96$1966**77.74**$\pm 3.05$**82.67**$\pm 1.74$**10.92**$\pm 1.22$**9.56**$\pm 0.97$1969**77.65**$\pm 3.13$**82.76**$\pm 1.86$**10.98**$\pm 1.17$**9.73**$\pm 0.99$1972**78.14**$\pm 2.69$**83.43**$\pm 1.61$**11.00**$\pm 1.16$**9.63**$\pm 1.09$1975**78.39**$\pm 2.43$**83.91**$\pm 1.71$**10.91**$\pm 1.14$**9.66**$\pm 1.18$1978**78.90**$\pm 2.10$**84.58**$\pm 1.69$**10.88**$\pm 1.02$**9.56**$\pm 1.33$1981**79.38**$\pm 1.90$**85.01**$\pm 1.71$**10.75**$\pm 1.01$**9.57**$\pm 1.26$1984**79.95**$\pm 1.92$**85.55**$\pm 1.73$**10.67**$\pm 0.98$**9.58**$\pm 1.15$1987**80.41**$\pm 1.79$**85.95**$\pm 1.75$**10.64**$\pm 1.01$**9.52**$\pm 1.12$1990**80.92**$\pm 1.78$**86.25**$\pm 1.96$**10.40**$\pm 0.85$**9.37**$\pm 1.21$1993**81.43**$\pm 2.10$**86.52**$\pm 2.32$**10.15**$\pm 0.78$**9.28**$\pm 1.06$1996**82.06**$\pm 2.12$**87.04**$\pm 2.18$**10.05**$\pm 0.95$**9.28**$\pm 1.08$1999**82.52**$\pm 1.97$**87.31**$\pm 2.22$**9.91**$\pm 1.04$**9.26**$\pm 0.88$2002**83.17**$\pm 2.00$**87.71**$\pm 2.32$**9.87**$\pm 1.09$**9.25**$\pm 0.82$2005**83.88**$\pm 2.04$**88.41**$\pm 2.19$**9.86**$\pm 1.24$**9.28**$\pm 0.85$2008**84.49**$\pm 1.97$**88.86**$\pm 2.13$**9.87**$\pm 1.34$**9.32**$\pm 0.85$2011**85.22**$\pm 1.90$**89.47**$\pm 2.10$**9.86**$\pm 1.32$**9.35**$\pm 0.79$*HMD, Period Tables: 1945--2011*. *15 Countries, (Last accessed 15/Jan/2020)*.

[Fig. 6](#fig6){ref-type="fig"} examines the (possible) dependence between the two regressions, and addresses the issue of whether errors or mis-estimates in one affect the other. In particular, the figure displays sorted residuals from the second (CLaM) regression -- which recall is for the compensation law of mortality in Eq. [(16)](#fd16){ref-type="disp-formula"} -- against the distribution of residuals from the first (GM) regression, in Eq. [(11)](#fd11){ref-type="disp-formula"}. Looking for top to bottom, notice that as the values of the CLaM [(16)](#fd16){ref-type="disp-formula"} residuals decline, there is little change (per the midpoint of the box and whisker plot) of the GM [(11)](#fd11){ref-type="disp-formula"} residuals. The Pearson correlation coefficient between the (midpoint of) residuals is effectively zero, and (further) justifies separating the two estimation procedures --- which recall was also driven by necessity.Fig. 5Estimated Gompertz parameters and their range over time. Note: This figure displays the historical Gompertz parameters using the $\left( m,b \right)$ formulation, based on the regression methodology described in the paper as phase \#1, across 15 countries from which historical data is available (to 1945) in the *HMD, last accessed 15/Jan/2020.* Shaded regions represent (+/-) 2 standards errors, listed in [Table 4a](#tbl4a){ref-type="table"}, [Table 4b](#tbl4b){ref-type="table"}.Fig. 6Robustness of the results: Comparing residuals. Note: Displays sorted residuals from the second (CLaM) regression, for the compensation law of mortality in Eq. [(16)](#fd16){ref-type="disp-formula"}, against the distribution of residuals from the first (GM) regression, in Eq. [(11)](#fd11){ref-type="disp-formula"}. Looking for top to bottom, notice that as the values of the CLaM [(16)](#fd16){ref-type="disp-formula"} residuals decline, there is little change (per the midpoint of the box plot) of the GM [(11)](#fd11){ref-type="disp-formula"} residuals. The Pearson correlation coefficients are close to zero, and (further) justifies separating the two estimation procedures.

On a related note this paper is silent on the issue of forward-looking stochastic mortality, and how longevity-risk-adjusted global age and the underlying mortality rates evolve over time, as per Lee--Carter for example. Rather, the current framework focuses on measuring risk-adjusted ages relative to some global benchmark at a single point in time, as opposed to forecasting how it evolves over time and whether or not it is stochastic. This paper is simply about presenting, explaining and comparing longevity-risk in a different way.Table 4bCompensation law: Historical coefficients (＋/−) 2SE.YearSlope: $\left( x^{\ast} \right)$Intercept $\left( L \right)$Growth $\left( G \right)$MaleFemaleMaleFemaleMaleFemale1945**81.71**$\pm 11.03$**69.14**$\pm 7.58$**−1.97**$\pm 1.01$**−3.41**$\pm 0.75$0.09120.09871948**92.88**$\pm 7.86$**73.66**$\pm 9.18$**−1.07**$\pm 0.69$**−3.05**$\pm 0.91$0.08780.09861951**90.46**$\pm 11.23$**73.74**$\pm 10.01$**−1.17**$\pm 1.03$**−3.00**$\pm 1.02$0.09110.10181954**87.37**$\pm 11.93$**71.35**$\pm 8.36$**−1.51**$\pm 1.10$**−3.33**$\pm 0.85$0.09180.10201957**91.31**$\pm 11.02$**74.71**$\pm 8.84$**−1.12**$\pm 1.01$**−2.99**$\pm 0.92$0.09180.10361960**87.28**$\pm 9.51$**73.10**$\pm 8.25$**−1.50**$\pm 0.89$**−3.21**$\pm 0.87$0.09300.10551963**85.71**$\pm 9.99$**74.51**$\pm 8.39$**−1.62**$\pm 0.93$**−3.06**$\pm 0.89$0.09290.10541966**87.03**$\pm 10.55$**72.94**$\pm 10.06$**−1.54**$\pm 0.97$**−3.28**$\pm 1.06$0.09190.10491969**86.79**$\pm 12.48$**69.71**$\pm 10.47$**−1.56**$\pm 1.14$**−3.62**$\pm 1.08$0.09130.10301972**84.38**$\pm 10.64$**74.46**$\pm 8.25$**−1.83**$\pm 0.97$**−3.20**$\pm 0.86$0.09110.10421975**80.19**$\pm 11.03$**72.73**$\pm 8.14$**−2.23**$\pm 1.02$**−3.43**$\pm 0.85$0.09190.10381978**79.23**$\pm 11.01$**73.96**$\pm 7.08$**−2.36**$\pm 1.01$**−3.37**$\pm 0.75$0.09210.10511981**78.85**$\pm 9.86$**76.55**$\pm 7.48$**−2.43**$\pm 0.92$**−3.14**$\pm 0.79$0.09320.10491984**81.50**$\pm 9.61$**79.82**$\pm 8.00$**−2.22**$\pm 0.90$**−2.86**$\pm 0.84$0.09390.10481987**81.76**$\pm 8.07$**83.23**$\pm 7.59$**−2.24**$\pm 0.76$**−2.54**$\pm 0.80$0.09420.10541990**80.82**$\pm 10.63$**83.38**$\pm 7.79$**−2.35**$\pm 1.02$**−2.54**$\pm 0.84$0.09630.10711993**82.75**$\pm 13.72$**86.66**$\pm 10.20$**−2.19**$\pm 1.35$**−2.22**$\pm 1.10$0.09870.10811996**88.05**$\pm 8.87$**89.08**$\pm 8.12$**−1.71**$\pm 0.89$**−2.01**$\pm 0.88$0.09970.10811999**86.16**$\pm 7.68$**92.74**$\pm 9.95$**−1.93**$\pm 0.78$**−1.64**$\pm 1.08$0.10120.10832002**85.30**$\pm 7.93$**92.36**$\pm 12.19$**−2.08**$\pm 0.81$**−1.72**$\pm 1.32$0.10160.10832005**85.25**$\pm 6.94$**92.54**$\pm 10.91$**−2.15**$\pm 0.71$**−1.78**$\pm 1.18$0.10180.10792008**85.37**$\pm 5.69$**91.18**$\pm 11.17$**−2.20**$\pm 0.58$**−1.98**$\pm 1.20$0.10170.10762011**85.70**$\pm 5.61$**86.92**$\pm 13.32$**−2.24**$\pm 0.57$**−2.51**$\pm 1.43$0.10180.1072*HMD, 15 Countries, Period Mortality: 1945--2011*. *Data Last accessed on 15/Jan/2020*.

As such, this paper is consistent with -- and in fact can be used to calibrate parameters in -- the work by [@b25], where the term *Biological Age* was used in the context of a lifecycle model. In that paper, mortality was assumed to evolve according to a Brownian Bridge (BB), and the stochastic process was inverted (via Gompertz, the same one used here) to arrive at a *Biological Age*. The estimates provided in this paper for (ages) $x^{\ast}$ and (rates) $\lambda^{\ast}$, can be used to pin down the end-points of the BB in [@b25], which were rather *ad hoc.* To be crystal clear, the current paper makes no attempt to forecast future longevity-risk-adjusted global ages $\xi\left( x,i \right)$, and is simply focused on measuring the dispersion in these ages around the world. Also, the current paper focused (much) more attention on the Makeham ($\lambda\left\lbrack i \right\rbrack$) term, which was ignored in [@b25]. In particular, the first regression (Eq. [(11)](#fd11){ref-type="disp-formula"}, in the current paper) uses an *iteration* procedure to locate the best-fitting values of the Makeham term, one that minimized the value of the standard errors. Ignoring the Makeham terms will result in erroneous estimates of series-specific lifespan $x^{\ast}$.

6. Conclusion {#sec6}
=============

The boxer Muhammad Ali is quoted as saying that: *Age is whatever you think it is. You are as old as you think you are*. Similarly, author Mark Twain joked that: *Age is just a state of mind. I say it is more about the state of your body.* Clearly, there is a wide divergence of opinions about the proper definition of *true age*, all of which are quite distinct from the number of times you circled the sun. In fact, recent work by [@b55] indicates that economic behavior is highly correlated with how old people *feel* versus their chronological age. The pertinent question here is whether actuarial science can contribute yet another age metric, one that is consistent with heterogeneous mortality and known mathematical theories of aging. This paper argues that the answer is yes.

This paper leverages the *compensation law of mortality* and the Gompertz--Makeham model to develop an expression for another measure of age, the longevity-risk-adjusted global age, denoted by L-RaG age. That is the main Eq. [(21)](#fd21){ref-type="disp-formula"} and contribution in the paper. In its approximate form, Eq. [(22)](#fd22){ref-type="disp-formula"} is a function of only: (1.) the local-relative-to-global mortality growth rate and (2.) the global plateauing age, which is the series-specific lifespan. The equation for $\xi\left( x,i \right)$ was then calibrated to (adult) one-year mortality decrements in 38 countries from the Human Mortality Database (circa 2011) using a two-phase regression methodology. Under this approach, the data indicate that for a male at chronological age 55, the gap in L-RaG ages between high-mortality (e.g. Russia) and low-mortality countries (e.g. Sweden), can be as high as 20 years. Stated differently, using the language of risk-adjusted benchmarks, your **true age** depends on where you live.

To be clear, the (large) gap in L-RaG ages identified in this paper should not be surprising or counterintuitive, and is consistent with (gaps in life expectancy as well as) research on health disparities around the world. For example, *ScienceDaily*, in an issue dated 8 March 2019, reported on research published in *The Lancet Public Health*, which showed a **30-year-gap** separating countries with the highest and lowest ages at which people experience the health problems of a global 65-year-old. That procedure is (technically) the opposite of the algorithm in this paper. They measured the age-related disease burden by aggregating disability adjusted life years (DALY) across 195 countries & territories over the period 1990--2017. According to those researchers, Japan has the highest *equivalent-age-to-a-global-65-year-old*, namely age 76.1, and Papua New Guinea had the lowest at 45.6 years. Once again, true age is relative.

6.1. Behavioral policy implications and uses {#sec6.1}
--------------------------------------------

The same $\xi\left( x,i \right)$ formula for the L-RaG age (and methodology) could be applied to heterogeneous groups within a country, for example mortality rates based on income, wealth, race or education. Recall that all that is really needed to properly use the simplified Eq. [(22)](#fd22){ref-type="disp-formula"} is a relative mortality growth rate $\kappa$ and a series-specific lifespan $x^{\ast}$. The rest is algebra.[13](#fn13){ref-type="fn"}

Now, one could just as easily use the same mortality rates to compare period life expectancy values between high-mortality and low-mortality countries and arrive at similarly large gaps between the two extremes. In fact, the Organization for Economic Co-operation and Development (OECD) regularly publishes reports comparing (more generally) quality of life across different countries and regions. However, one could argue that there are behavioral (a.k.a. psychological) reasons and benefits to *anchoring* on longevity-risk-adjusted global ages versus life expectancy, since -- simply put -- these numbers are more memorable. In fact, one can show that the gap in longevity-risk-adjusted global ages for two individuals who share the same chronological age but are on opposite sides of $G$, will actually be larger than the gap in life expectancy.

For example, imagine we have (only) two groups, with mortality growth rates $g_{P} = 8\text{\%}$ and $g_{R} = 12\text{\%}$ respectively. Perhaps the former group is of low income (and poor health) while the latter has higher income (and better health). Assuming a species-specific lifespan of $x^{\ast} = 100$, an average mortality growth rate of $10\text{\%}$ and a mortality plateau $\lambda^{\ast} = e^{- 1}$, we can say the following: integrating the survival probability from age 65 to age 100, the life expectancy at age $x = 65$ for all members of group $P$ is: $E\left\lbrack T_{65}\left( 0.08 \right) \right\rbrack = 15.8$ years. For members of group $R$ the equivalent number is: $E\left\lbrack T_{65}\left( 0.12 \right) \right\rbrack = 22.3$ years, and the population life expectancy would be $E\left\lbrack T_{65}\left( 0.10 \right) \right\rbrack = 19.3$ years. So, the life expectancy gap between the two sub-groups is approximately $22.3 - 15.8 = 6.5$ years at age 65. To compare, the longevity-risk-adjusted global age of the (chronological) 65 year-old in group $P$ is 72, versus 58 for group $R$, according to Eq. [(22)](#fd22){ref-type="disp-formula"}. That is a gap of 14 years and is likely more *salient.*

Arguably, notifying a 65-year-old that their (true) age is 58 might help them take action, such as delaying retirement. Compare this -- again, with a behavioral framework in mind -- to informing said person that their life expectancy is actually 22 years, versus the population average of 19, and they should therefore wait to draw their pension. Likewise, a risk-adjusted definition of age opens the door to discussions around retirement policy geared towards demographic parameters: perhaps retirement age should be based on a longevity-risk-adjusted global age versus chronological age. This would obviously be controversial[14](#fn14){ref-type="fn"} and goes well beyond the technical scope of this article.

At the very least then, as we get close to celebrating the 200-year anniversary of the publication of the work of Benjamin Gompertz, this paper offers yet another application of his timeless model. He was the first to teach the world how to mathematically map **from** chronological age into hazard rates. This paper argues the same idea can be used in the other direction, namely to convert hazard rates **into** a world-averaged age.
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According to Google Scholar, no fewer than 100 papers published in *IME* over the last decade have assumed or cited a non-trivial Gompertz law. In particular Gompertz remains quite popular in (i.) the valuation of annuities, (ii.) retirement income strategies and (iii.) stochastic mortality models. See for example: [@b1], [@b7], [@b9], [@b10], [@b12], [@b11], [@b14], [@b13], [@b16], [@b17], [@b18], [@b23], [@b24], [@b27], [@b31], [@b30], [@b32], [@b33], [@b34], [@b38], [@b41], [@b42], [@b46], [@b49], [@b51], [@b52], [@b53] and [@b54].

See the work by [@b19], [@b20] for a defense of the Gompertz assumption, even at very advanced ages, as well as [@b2] for related work.

See the work by [@b39], and their various references for more evidence on the difficulty consumers face with basic probabilistic information, especially as it relates to retirement income planning.

The inversion process would be more difficult with general mortality laws -- see [@b43] for an approach to modeling compensation laws with splines -- and will be examined in future research.

See [@b15], [@b26], [@b28] and [@b44], for more on this (conventional) approach to biological age estimation and their many references.

Since both: $h\left\lbrack i \right\rbrack$ and $\lambda\left\lbrack i \right\rbrack$ tend to be very small numbers, that is, on the order of 10^−5^, most of the tables and figures will display the natural log values.

The material in this section is an extended version of a procedure first introduced and used in the brief technical appendix of [@b35] within the context of mortality heterogeneity across US income percentiles and the value of annuitization. That derivation is reproduced (and expanded) in this section, focused more broadly on global mortality rates and within the context of estimating risk-adjusted ages, which was not the focus of [@b35].

Most published estimates of $C_{0}$ and $C_{1}$ in the economic literature, such as [@b8], or [@b37], use $\ln\left\lbrack q_{x} \right\rbrack$ on the left-hand side, without subtracting a Makeham term.

Please refer to the recent work by [@b50] for a full and proper discussion of the many and diverse methods that can be used to estimate Gompertz parameters from one-year decrements, and in particular the approach that minimizes root mean square (RMS) errors for life expectancy estimates.

The entire algorithm (both regressions) is coded-up by the author in R, and freely available for use and replication at <https://github.com/asosnovsky/Longevity-Risk-adjusted-Global-Age/releases/tag/1.3.1>.

Recall that under the $\left( m,b \right)$ formulation of the Gompertz--Makeham law, $h = \left( 1\slash b \right)e^{- m \slash b}$ and $\left. g = 1\slash b \right.$, when the total hazard rate is modeled as: $\mu_{x} = he^{gx}$. So, a linear relationship between $\ln\left\lbrack h \right\rbrack = L - x^{\ast}g$, per the compensation law of mortality, also forces a relationship between $m$ and $b$, although the relationship is obviously not linear. Fixing $b$, together with the global parameters $\left( L,x^{\ast} \right)$, induces a value for $m$. Technically, after substitution and isolating: $m = x^{\ast} - b\left( L + \ln\left\lbrack b \right\rbrack \right)$. So, if one assumes the easy-to-remember values: $x^{\ast} = 100$, and: $L = - 1$, both of which are empirically reasonable per [Table 2](#tbl2){ref-type="table"}, then the modal value of the Gompertz distribution is forced to be: $m = 100 - b\left( \ln\left\lbrack b \right\rbrack - 1 \right)$. Thus, for example, in a country (or population) where $b = 11$ then $m = 84.62$, but if $b = 9$ then $m = 89.2$. A greater $b$ induces a lower value of $m$ and vice versa. Finally, since the expected remaining lifetime at birth under a Gompertz model is: $E\left\lbrack T_{0} \right\rbrack = m - b\gamma$, where $\gamma \approx 0.577$, is Euler's constant, we obtain the rather intriguing expression $E\left\lbrack T_{0} \right\rbrack = x^{\ast} - b\left( L + \ln\left\lbrack b \right\rbrack + \gamma \right)$ under the compensation law. Estimate or pick the dispersion coefficient $b$ (or the approximate standard deviation $\left. \pi b\slash\sqrt{6} \right.$ at birth) and the mean lifetime follows, assuming of course that $\left( L,x^{\ast} \right)$ are globally determined.

To this point, it is noted that [@b6] write in relation to the *compensation law of mortality* that "\...we have not found any evidence that groups cross over, even at very high ages\...".

Employing the main equation for longevity-risk-adjusted global age with Gompertz coefficients by income percentile in the US, as reported by [@b8], results in a gap of almost 20 years. See [@b36] as well.

See the paper by [@b48] for a survey and discussion of the various ways to adjust retirement ages for increases in longevity and life expectancy, and the work of [@b47] as well as the recent book by [@b45] which introduces a number of other age-based metrics that could be used for retirement policy.

[^1]: Note: These are the results from regressing the (male and female) Gompertz--Makeham (log) mortality intercepts $\ln h\left\lbrack i \right\rbrack$ on the mortality growth rates $g\left\lbrack i \right\rbrack$. This is the second phase regression. Note that $\left( - x^{\ast} \right)$ are significant at very high levels, but the intercept $\left( L \right)$ for females is only significant at the $95\text{\%}$ level.
